ATL boasts record financial results

Article

ATL Ultrasound had another record year, buoyed by an especially strong fourth quarter. Although its 1997 revenues advanced only 2.9% for the year, the company experienced a 9% revenue increase in the fourth quarter.For the fourth quarter (end-December),

ATL Ultrasound had another record year, buoyed by an especially strong fourth quarter. Although its 1997 revenues advanced only 2.9% for the year, the company experienced a 9% revenue increase in the fourth quarter.

For the fourth quarter (end-December), ATL had revenues of $137.3 million, compared with $125.5 million in 1996. Net income was $18.5 million, compared with $11.6 million last year. Company officials credited shipments of its premium HDI 5000 system as a key factor in the results.

For the year, ATL had revenues of $431.2 million, compared with $419.2 million in 1996. Net income was $21.2 million, compared with a 1996 net loss of $828,000, which included a nonrecurring charge of $29.6 million for patent litigation damages.

In other ATL news, the company announced that it will spin off its Handheld Systems Business division as an independent public company. The deal will result in a tax-free stock dividend to ATL shareholders on a basis of one share in the new company for every three ATL shares.

Pending review by the Securities and Exchange Commission, ATL anticipates the stock distribution will occur in April, and will result in a one-time $1.5 million charge in the first quarter. Kevin Goodwin, who has served as vice president and general manager of the Handheld Systems Business, will become president and CEO of the new company.

Meanwhile, technology developed at the division continues to move closer to commercialization. The division is first developing a device targeted for the women's health market, with future models slated for internal and emergency medicine applications. A prototype is expected to be finished within the next few months, according to ATL. The new company will file a 510(k) application with the Food and Drug Administration within the next month, with a commercial launch anticipated in 1999.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.